These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35980197)

  • 1. Impact of antimetabolite discontinuation following cytomegalovirus or BK polyoma virus infection in kidney transplant recipients.
    Dubrawka CA; Progar KJ; January SE; Hagopian JC; Nesselhauf NM; Malone AF
    Transpl Infect Dis; 2022 Dec; 24(6):e13931. PubMed ID: 35980197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients.
    Huang HX; Xiang Y; George R; Winterberg P; Serluco A; Liverman R; Yildirim I; Garro R
    Pediatr Transplant; 2024 Aug; 28(5):e14791. PubMed ID: 38808701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
    Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
    J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
    Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
    Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.
    Reischig T; Kacer M; Hes O; Machova J; Nemcova J; Lysak D; Jindra P; Pivovarcikova K; Kormunda S; Bouda M
    Am J Transplant; 2019 Sep; 19(9):2457-2467. PubMed ID: 31220412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing net immunosuppression after BK polyoma virus infection.
    Cotiguala L; Masood A; Park JM; Samaniego-Picota MD; Kaul DR; Naik AS
    Transpl Infect Dis; 2021 Apr; 23(2):e13472. PubMed ID: 32959930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a reduced frequency viral monitoring strategy for Epstein-Barr virus, cytomegalovirus, and BK polyomavirus post-kidney transplant: A quality assurance initiative.
    Rampersad C; Kong W; Wiebe C; Balshaw R; Bullard J; Villalobos APC; Trachtenberg A; Shaw J; Karpinski M; Nickerson PW; Ho J
    Clin Transplant; 2024 Apr; 38(4):e15292. PubMed ID: 38545888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
    Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
    Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients.
    Rampersad C; Wiebe C; Balshaw R; Bullard J; Gibson IW; Trachtenberg A; Shaw J; Villalobos APC; Karpinski M; Goldberg A; Birk P; Pinsk M; Rush DN; Nickerson PW; Ho J
    Clin Transplant; 2024 May; 38(5):e15329. PubMed ID: 38722085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of BK viremia is associated with a lower risk of subsequent cytomegalovirus infection in kidney transplant recipients.
    Jorgenson MR; Descourouez JL; Lyu B; Astor BC; Saddler CM; Mandelbrot DA; Parajuli S
    Clin Transplant; 2020 Mar; 34(3):e13798. PubMed ID: 31994787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BK polyomavirus DNAemia in pancreas transplant recipients compared to pancreas-kidney recipients.
    Yetmar ZA; Kudva YC; Seville MT; Bosch W; Dean PG; Huskey JL; Budhiraja P; Jarmi T; Kukla A; Beam E
    Clin Transplant; 2023 Nov; 37(11):e15135. PubMed ID: 37705389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of Torque Teno viral load with CMV and BKV infection in pediatric and adolescent kidney transplant patients.
    Eibensteiner F; Messner I; Uhl P; Bond G; Puchhammer-Stoeckl E; Mueller-Sacherer T; Aufricht C; Rusai K
    J Clin Virol; 2024 Jun; 172():105673. PubMed ID: 38564881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients.
    Ginevri F; Azzi A; Hirsch HH; Basso S; Fontana I; Cioni M; Bodaghi S; Salotti V; Rinieri A; Botti G; Perfumo F; Locatelli F; Comoli P
    Am J Transplant; 2007 Dec; 7(12):2727-35. PubMed ID: 17908275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
    Westphal SG; Lyden ER; Langewisch ED; Miles CD
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis.
    Chaiyapak T; Borges K; Williams A; Banh T; Vasilevska-Ristovska J; Allen U; Parekh RS; Hébert D
    Transplantation; 2018 Aug; 102(8):1391-1396. PubMed ID: 29377877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients.
    Reischig T; Vlas T; Kacer M; Pivovarcikova K; Lysak D; Nemcova J; Drenko P; Machova J; Bouda M; Sedivcova M; Kormunda S
    J Am Soc Nephrol; 2023 May; 34(5):920-934. PubMed ID: 36749127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral specific T cell therapy in kidney transplant recipients - A single-center experience.
    Anand M; Nysather J; McGraw G; Apewokin S; Khoury R; Grimley MS; Bumb S; Govil A
    Transpl Infect Dis; 2023 Dec; 25(6):e14179. PubMed ID: 37910558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation.
    Jehn U; Schütte-Nütgen K; Bautz J; Pavenstädt H; Suwelack B; Thölking G; Reuter S
    Sci Rep; 2020 Dec; 10(1):22406. PubMed ID: 33376243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of BK polyomavirus infection and association with renal dysfunction in pediatric heart transplant recipients.
    Ducharme-Smith A; Katz BZ; Bobrowski AE; Backer CL; Rychlik K; Pahl E
    J Heart Lung Transplant; 2015 Feb; 34(2):222-6. PubMed ID: 25540880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.